GLICLAZIDE MR VIATRIS gliclazide 30 mg modified release tablet blister pack

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Aktív összetevők:

gliclazide, Quantity: 30 mg

Beszerezhető a:

Alphapharm Pty Ltd

Gyógyszerészeti forma:

Tablet, modified release

Összetétel:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; hypromellose

Az alkalmazás módja:

Oral

db csomag:

100

Recept típusa:

(S4) Prescription Only Medicine

Terápiás javallatok:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Termék összefoglaló:

Visual Identification: A white to off-white, oblong, biconvex tablet debossed with M on one side of the tablet and GL 30 on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Engedélyezési státusz:

Registered

Engedély dátuma:

2023-03-31